MeSH term | MeSH ID | Detail |
---|---|---|
Pancreatic Neoplasms | D010190 | 77 associated lipids |
Body Weight | D001835 | 333 associated lipids |
Arteriosclerosis | D001161 | 86 associated lipids |
Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.
To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Norethindrone
MeSH term | MeSH ID | Detail |
---|---|---|
Pancreatic Neoplasms | D010190 | 77 associated lipids |
Body Weight | D001835 | 333 associated lipids |
Arteriosclerosis | D001161 | 86 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Chryssikopoulos A et al. | Cyclic and individualized administration of gonadotropin-releasing hormone agonists plus progestogens: an alternative protocol for contraception. | 1997 | Gynecol. Endocrinol. | pmid:9174853 |
Saxena BN et al. | Radioimmunoassay of serum norethisterone oenanthate levels in women after intramuscular administration. | 1977 | J. Steroid Biochem. | pmid:916668 |
Greyling MD et al. | Ligand specificity of uterine oestrogen and progesterone receptors in the subadult African elephant, Loxodonta africana. | 1997 | J. Reprod. Fertil. | pmid:9155728 |
Hanson RM and Melzer DJ | Estrogen replacement therapy: new options, continuing concerns. | 1997 | JAMA | pmid:9153359 |
Seeking new methods. | 1977 | People | pmid:913851 | |
Schwingl PJ and Shelton J | Modeled estimates of myocardial infarction and venous thromboembolic disease in users of second and third generation oral contraceptives. | 1997 | Contraception | pmid:9114999 |
Mueck AO et al. | Influence of norethisterone acetate and estradiol on the serotonin metabolism of postmenopausal women. | 1997 | Horm. Metab. Res. | pmid:9105905 |
Tilly-Kiesi M et al. | Responses of HDL subclasses, Lp(A-I) and Lp(A-I:A-II) levels and lipolytic enzyme activities to continuous oral estrogen-progestin and transdermal estrogen with cyclic progestin regimens in postmenopausal women. | 1997 | Atherosclerosis | pmid:9105568 |
Patton DL et al. | Oral contraceptives do not alter the course of experimentally induced chlamydial salpingitis in monkeys. | 1994 Mar-Apr | Sex Transm Dis | pmid:9071418 |
Rosenfeld WE et al. | Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy. | 1997 | Epilepsia | pmid:9070594 |